Prevalence of mental disorders in patients with cancer compared to matched controls – secondary analysis of two nationally representative surveys
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
AIM: To compare prevalence rates of mental disorders in patients with cancer and general population controls. METHOD: In two stratified nationally representative surveys, the 12-month prevalence of mental disorders was assessed in 2141 patients with cancer and 4883 general population controls by the standardized Composite International Diagnostic Interview (CIDI). We determined odds ratios (ORs) to compare the odds for mental disorders (combined and subtypes) in cancer patients with age- and gender-matched controls. RESULTS: The 12-month prevalences rate for any mental disorder was significantly higher in patients with cancer compared to controls (OR 1.28, 95% CI 1.14-1.45). Prevalence rates were at least two times higher for unipolar mood disorders (major depression: OR 2.07, 95% CI 1.71-2.51; dysthymia: OR 2.93, 95% CI 2.13-4.02) and mental disorders due to a general medical condition (OR 3.31, 95% CI 2.32-4.71). There was no significant elevation for anxiety disorders overall (OR 0.95, 95% CI 0.81-1.11). Mildly elevated prevalence rates emerged for post-traumatic stress disorder (OR 1.57, 95% CI 1.11-2.23) and social phobia (OR 1.57, 95% CI 1.07-2.31), while specific phobia (OR 0.82, 95% CI 0.67-1.00) and agoraphobia (OR 0.49, 95% CI 0.33-0.73) were significantly less frequent in cancer. CONCLUSIONS: While elevated depression rates reinforce the need for its systematic diagnosis and treatment, lower prevalences were unexpected given previous evidence. Whether realistic illness-related fears and worries contribute to lower occurrence of anxiety disorders with excessive fears in cancer may be of interest to future research.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In comparison with a control group, depression prevalence rates among people with cancer are at least two times higher for unipolar mood disorders (major depression: OR, 2.07; 95% CI, 1.71 to 2.51; dysthymia: OR, 2.93; 95% CI, 2.13 to 4.02).4”
From Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update (2023) · cites this paper as [4]
In the citing paper
“In comparison with a control group, depression prevalence rates among people with cancer are at least two times higher for unipolar mood disorders (major depression: OR, 2.07; 95% CI, 1.71 to 2.51; dysthymia: OR, 2.93; 95% CI, 2.13 to 4.02).4”
From Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update (2023) · cites this paper as [4]
Citations
Cites
Austin, P. C., & Stuart, E. A. (2015) · Statistics in Medicine · doi:10.1002/sim.6607 · Cited by 4,495 · cited 1×
“sample to match the age and gender distribution in the cancer sample [22,23].”
BackgroundAnxiety and depression after cancer diagnosis: Prevalence rates by cancer type, gender, and age
Linden, W., Vodermaier, A., MacKenzie, R., & Greig, D. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.03.025 · Cited by 1,245 · cited 1×
“While it has been established that, within cancer populations, younger and female individuals are more distressed [15], it is not clear whether this pattern exceeds the same effect in the general population were mental disorders are also more frequent in those groups.”
BackgroundDepression and anxiety in patients with cancer
Pitman, A., Suleman, S., Hyde, N., & Hodgkiss, A. (2018) · BMJ · doi:10.1136/bmj.k1415 · Cited by 871 · cited 2×
“Living with a life-threatening disease may lead to an increased psychosocial burden as individuals confront a variety of stressors throughout the disease trajectory [4].”
BackgroundFour-Week Prevalence of Mental Disorders in Patients With Cancer Across Major Tumor Entities
Mehnert, A., Brähler, E., Faller, H., Härter, M., Keller, M., Schulz, H., Wegscheider, K., Weis, J., Boehncke, A., Hund, B., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.0086 · Cited by 649 · cited 3×
“Cancer patients were recruited in a multicenter cross-sectional study from the following treatment settings: oncological inpatient clinics at acute care hospitals, specialized outpatient cancer care facilities, and inpatient cancer rehabilitation centers across Germany between July 2008 and December 2010 [16,19].”
BackgroundSelf-citationJacobi, F., Höfler, M., Siegert, J., Mack, S., Gerschler, A., Scholl, L., Busch, M. A., Hapke, U., Maske, U., Seiffert, I., et al. (2014) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1439 · Cited by 586
Depression in cancer patients: Pathogenesis, implications and treatment (Review)
SMITH, H. R. (2015) · Oncology Letters · doi:10.3892/ol.2015.2944 · Cited by 478
Walker, J., Hansen, C. H., Martin, P., Symeonides, S., Ramessur, R., Murray, G., & Sharpe, M. (2014) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)70313-x · Cited by 435
Scheidt-Nave, C., Kamtsiuris, P., Gößwald, A., Hölling, H., Lange, M., Busch, M. A., Dahm, S., Dölle, R., Ellert, U., Fuchs, J., et al. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-730 · Cited by 403 · cited 1×
“The presence of these chronic health conditions was assessed as part of the DEGS1 procedures by a standardized physician-administered computer-based health interview and examination, standardized measurements, and laboratory tests [20].”
MethodGlare, P. A., Davies, P. S., Finlay, E., Gulati, A., Lemanne, D., Moryl, N., Oeffinger, K. C., Paice, J. A., Stubblefield, M. D., & Syrjala, K. L. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.4629 · Cited by 329 · cited 1×
“Complex chronic pain is frequent in cancer survivors, and might be associated with a higher risk for pain disorder when untreated [27].”
BackgroundSharpe, M., Walker, J., Hansen, C. H., Martin, P., Symeonides, S., Gourley, C., Wall, L., Weller, D., & Murray, G. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61231-9 · Cited by 269 · cited 1×
“The elevated 12-month prevalence rate for unipolar depression strengthens the need for systematic diagnosis, treatment, and follow-up of depression in patients with cancer as shown effective through for example integrated collaborative care programs [29].”
Background
Research works printed but not linked: 3
- DiMatteo MR, 2011, Depression and cancer, 101
- Rogers R, 2019, Cambridge handbook of psychology, health and medicine, 179
- Pirl WF, 1999, Oncology, 13, 1305
Cited by
Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update
Andersen, B. L., Lacchetti, C., Ashing, K., Berek, J. S., Berman, B. S., Bolte, S., Dizon, D. S., Given, B., Nekhlyudov, L., Pirl, W., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.00293 · Cited by 318
“02).(4) Using self-report instruments with specified cutoff points (eg, Patient Health Questionnaire-9 $ 10), moderate to severe depressive symptom rates between 13% and 27% have been reported.”
BackgroundCarlson, L. E., Ismaila, N., Addington, E. L., Asher, G. N., Atreya, C., Balneaves, L. G., Bradt, J., Fuller-Shavel, N., Goodman, J., Hoffman, C. J., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.00857 · Cited by 309
“45]).(4) A systematic review (SR) of 210 studies reported the mean prevalence of clinical depression as 21.”
BackgroundThe Impact of Cancer on Mental Health and the Importance of Supportive Services
Fereidouni, Z., Abnavi, S. D., Ghanbari, Z., Gashmard, R., Zarepour, F., Samani, N. K., Sharma, A. R., & Ghasemi, A. (2024) · Galen Medical Journal · doi:10.31661/gmj.v13i.3327 · Cited by 90
“However, research indicates that up to one-third of cancer patients experience symptoms of anxiety and depression during their treatment procedures [10].”
BackgroundThe human crisis in cancer: a Lancet Oncology Commission
Rodin, G., Feldman, A., Trapani, D., Skelton, M., Unger‐Saldaña, K., Essue, B. M., Pihlak, R., Walshe, C., Rosa, W. E., Banegas, M. P., et al. (2025) · The Lancet Oncology · doi:10.1016/s1470-2045(25)00530-3 · Cited by 79
Carlson, L. E., Ismaila, N., Addington, E. L., Asher, G. N., Bradt, J., Mehta, A., & Rowland, J. H. (2023) · JCO Oncology Practice · doi:10.1200/op.23.00358 · Cited by 26
Metadata
- Authors
- Vehling, S., Mehnert-Theuerkauf, A., Philipp, R., Härter, M., Kraywinkel, K., Kuhnert, R., & Koch, U.
- Affiliations
- University Medical Center Hamburg-Eppendorf (DE)
- University Hospital Leipzig (DE)
- Robert Koch Institute (DE)
- Corresponding author
- Vehling, Sigrun
- Venue
- Acta Oncologica
- Published
- 2021-11-03
- Volume
- 61
- Issue
- 1
- Pages
- 7-13
- ISSN
- 0284-186X (ISSN-L)
- 1651-226X
- OpenAlex
- W3208567709
- Cited by
- 55
- References
- 30
- Citations by year
- 2026: 15 · 2025: 11 · 2024: 20 · 2023: 7 · 2022: 1 · 2021: 1
- FWCI
- 2.64
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Acta Oncologica (publishedVersion)
- PubMed (publishedVersion)
- Funders
- German Cancer Aid (107465)
- Max-Eder junior research group program of the German Cancer Aid (70113404)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- cancer patients, mental illness, prevalence, depression, dysthymia, anxiety disorders, post-traumatic stress disorder, social anxiety disorder, specific phobia, agoraphobia
- MeSH terms
- Anxiety Disorders, Health Surveys, Humans, Neoplasms, Phobic Disorders, Prevalence, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence of mental disorders in patients with cancer compared to matched controls – secondary analysis of two nationally representative surveys. https://app.cochat.ai/papers/10.1080/0284186x.2021.1992008
- The paper
- Vehling, S., Mehnert-Theuerkauf, A., Philipp, R., Härter, M., Kraywinkel, K., Kuhnert, R., & Koch, U. (2022). Prevalence of mental disorders in patients with cancer compared to matched controls – secondary analysis of two nationally representative surveys. Acta Oncologica. https://doi.org/10.1080/0284186x.2021.1992008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.